Latest filing published 08 Apr 2020 for ANI Pharmaceuticals INC, €131k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Arthur Przybyl: trading record in brief
Filings by Arthur Przybyl span 2 companies, the busiest being ANI Pharmaceuticals Inc and Akorn Inc. The record holds 132 filings, for trades running from 31 March 2006 to 7 April 2020.
The open-market side counts 2 purchases for €116k alongside 16 sales for €13.9M. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 84 share grants and 26 option exercises.
Most recently, on 8 April 2020, the filings show a share grant worth €85k in ANI Pharmaceuticals Inc. The clock since the last published purchase (12 November 2015) now reads 4,014 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Arthur Przybyl
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,282 shares@ US$43.2228.6% of flowCommon StockSEC:0001104659-20-044729:0
- 2,115 shares@ US$43.9318.6% of flowCommon StockSEC:0001104659-20-044729:1
- 4,204 shares@ US$37.7631.3% of flowCommon StockSEC:0001104659-20-041406:0
- 2,679 shares@ US$40.7421.6% of flowCommon StockSEC:0001104659-20-041406:1
- 9,595 shares@ US$71.1012.5% of flowCommon StockSEC:0001144204-19-026662:0
- 5,772 shares@ US$70.457.5% of flowCommon StockSEC:0001144204-19-026662:1
- 14,633 shares@ US$69.2518.6% of flowCommon StockSEC:0001144204-19-026662:2
- 1,692 shares@ US$68.602.1% of flowCommon StockSEC:0001144204-19-020282:0
- 3,282 shares@ US$70.504.2% of flowCommon StockSEC:0001144204-19-018898:0
- 2,115 shares@ US$70.502.7% of flowCommon StockSEC:0001144204-19-018898:1
- 2,678 shares@ US$70.543.5% of flowCommon StockSEC:0001144204-19-017765:0
- 37,280 shares0Common StockSEC:0001144204-19-017410:0
- 24,802 shares@ US$63.5328.6% of flowCommon StockSEC:0001144204-19-015117:0
- 2,823 shares@ US$63.513.3% of flowCommon StockSEC:0001144204-19-015117:1
- 1,375 shares@ US$61.880.6% of flowCommon StockSEC:0001144204-18-030788:0
- 1,611 shares@ US$60.210.7% of flowCommon StockSEC:0001144204-18-021177:0
- 29,100 shares0Common StockSEC:0001144204-18-019986:0
- 2,014 shares@ US$57.060.8% of flowCommon StockSEC:0001144204-18-019986:1
- 2,550 shares@ US$58.221.0% of flowCommon StockSEC:0001144204-18-019005:0
- 15,723 shares@ US$6.360.7% of flowCommon StockSEC:0001144204-18-014729:0
- 23,475 shares@ US$61.5210.0% of flowCommon StockSEC:0001144204-18-014729:1
- 6,525 shares@ US$62.632.8% of flowCommon StockSEC:0001144204-18-014729:2
- 10,000 shares@ US$62.034.3% of flowCommon StockSEC:0001144204-18-014729:3
- 9,375 shares@ US$40.592.7% of flowCommon StockSEC:0001144204-18-012823:0
- 6,375 shares@ US$33.001.5% of flowCommon StockSEC:0001144204-18-012823:1
25 of 132 declarations